Image: Courtesy of Andrew Leuchter et al.
Scientists have recognized for some time that people suffering from depression often experience a substantial reduction in symptoms when given a placebo. In fact, this observation has led some researchers to propose that up to 75 percent of the apparent efficacy of antidepressant medicine may actually be attributable to the placebo effect. Determining the cause of a patient’s improvement under such circumstances is no easy task. But the results of a new study may shed light on the matter. According to a report in the January issue of the American Journal of Psychiatry, depressed patients who respond to placebo treatment do exhibit a change in brain function, but one that differs from that seen in patients who respond to medication.
Using so-called quantitative electroencephalography imaging, a team of researchers at the University of California at Los Angeles studied electrical activity in the brains of 51 depressed patients receiving either placebo treatment or active medication. Patients who responded favorably to the placebo, the investigators found, showed increased activity in a region of the brain known as the prefrontal cortex. Those who responded to medication, in contrast, exhibited suppressed activity in that area. The image shown here illustrates changes in prefrontal cortex activity over time in the placebo responders group (top row) and the medication responders group (bottom row), with red indicating an increase in activity and blue-green representing a decrease. "Both treatments affect prefrontal brain function," the researchers write, "but they have distinct effects and time courses."
These results "show us that there are different pathways to improvement for people suffering from depression," team member Andrew Leuchter notes. “Medications are effective, but there may be other ways to help people get better," he adds. "If we can identify what some of the mechanisms are that help people get better with placebo, we may be able to make treatments more effective.”
Kate Wong | Scientific American
Sugar entering the brain during septic shock causes memory loss
23.04.2019 | Rensselaer Polytechnic Institute
Deep stimulation improves cognitive control by augmenting brain rhythms
04.04.2019 | Picower Institute at MIT
Researchers led by Francesca Ferlaino from the University of Innsbruck and the Austrian Academy of Sciences report in Physical Review X on the observation of supersolid behavior in dipolar quantum gases of erbium and dysprosium. In the dysprosium gas these properties are unprecedentedly long-lived. This sets the stage for future investigations into the nature of this exotic phase of matter.
Supersolidity is a paradoxical state where the matter is both crystallized and superfluid. Predicted 50 years ago, such a counter-intuitive phase, featuring...
A stellar flare 10 times more powerful than anything seen on our sun has burst from an ultracool star almost the same size as Jupiter
A localization phenomenon boosts the accuracy of solving quantum many-body problems with quantum computers which are otherwise challenging for conventional computers. This brings such digital quantum simulation within reach on quantum devices available today.
Quantum computers promise to solve certain computational problems exponentially faster than any classical machine. “A particularly promising application is the...
The technology could revolutionize how information travels through data centers and artificial intelligence networks
Engineers at the University of California, Berkeley have built a new photonic switch that can control the direction of light passing through optical fibers...
Physicists observe how electron-hole pairs drift apart at ultrafast speed, but still remain strongly bound.
Modern electronics relies on ultrafast charge motion on ever shorter length scales. Physicists from Regensburg and Gothenburg have now succeeded in resolving a...
17.04.2019 | Event News
15.04.2019 | Event News
09.04.2019 | Event News
23.04.2019 | Information Technology
23.04.2019 | Earth Sciences
23.04.2019 | Life Sciences